Electronics

Senseonics

$2.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.64 (+27.71%) Today
-$0.10 (-3.39%) As of 12:14 PM UTC after-hours

Why Robinhood?

You can buy or sell Senseonics and other stocks, options, and ETFs commission-free!

About SENS

Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD. The listed name for SENS is Senseonics Holdings, Inc.

CEO
Timothy T. Goodnow
Employees
191
Headquarters
Germantown, Maryland
Founded
2014
Market Cap
837.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
123.18M
High Today
$2.97
Low Today
$2.50
Open Price
$2.93
Volume
102.50M
52 Week High
$3.90
52 Week Low
$0.3497

Collections

SENS News

BenzingaJan 20

Return On Capital Employed Overview: Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc. Common Stock (AMEX:SENS) reported Q3 sales of $767.00 thousand. Earnings fell to a loss of $12.47 million, resulting in a 0.46% decrea
BenzingaJan 20

Why Senseonics Shares Spiked 87% Today

Senseonics Holdings, Inc (AMEX: SENS) shares spiked nearly 87% in the regular and after-hour sessions on Tuesday. What Happened: The medical technology company

SENS Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

BSMU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure